Proteomics

Dataset Information

0

Impact of abacavir and abacavir analogues on HLA-B*57:01 peptide presentation

ABSTRACT: Characterisation of peptide ligands of the Major histocompatibility class (MHC) I allele, HLA-B*57:01, expressed in the C1R (Class I reduced) B-lymphoblastoid cell line, after exposure to the anti-retroviral abacavir or abacavir analogues.

INSTRUMENT(S): TripleTOF 5600

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Suspension Culture

SUBMITTER: Patricia Illing  

LAB HEAD: Anthony W. Purcell

PROVIDER: PXD015398 | Pride | 2019-10-03

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
20170328_Pat_ABCan_CIRB5701un_pool1.wiff Wiff
20170328_Pat_ABCan_CIRB5701un_pool1.wiff.scan Wiff
20170328_Pat_ABCan_CIRB5701un_pool2.wiff Wiff
20170328_Pat_ABCan_CIRB5701un_pool2.wiff.scan Wiff
20170328_Pat_ABCan_CIRB5701un_sp2017.group Other
Items per page:
1 - 5 of 263
altmetric image

Publications

Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation.

Thomson Paul J PJ   Illing Patricia T PT   Farrell John J   Alhaidari Mohammad M   Bell Catherine C CC   Berry Neil N   O'Neill Paul M PM   Purcell Anthony W AW   Park Kevin B KB   Naisbitt Dean J DJ  

Allergy 20191009 3

<h4>Background</h4>Abacavir is associated with hypersensitivity reactions in individuals positive for the HLA-B*57:01 allele. The drug binds within the peptide binding groove of HLA-B*57:01 altering peptides displayed on the cell surface. Presentation of these HLA-abacavir-peptide complexes to T-cells is hypothesized to trigger a CD8<sup>+</sup> T-cell response underpinning the hypersensitivity. Thus, the aim of this study was to explore the relationship between the structure of abacavir with HL  ...[more]

Similar Datasets

Proteomics C1R.B*57:01 MHC class I immunopeptidome LC-MSMS
2018-10-24 | PXD008570 | Pride
Proteomics C1R.B*57:03 MHC class I immunopeptidome LC-MSMS
2018-10-24 | PXD008571 | Pride
Proteomics C1R.B*58:01 MHC class I immunopeptidome LC-MSMS
2018-10-24 | PXD008572 | Pride
Proteomics DDA acquisition of the immunopeptidomes of C1R-B*57:01 and C1R-A*02:01 cell lines
2023-02-13 | PXD034429 | Pride
Proteomics C1R.A*01:01, C1R.A*02:01, C1R.A*24:02 MHC class I immunopeptidome LC-MSMS
2020-07-27 | PXD014754 | Pride
Proteomics Impacts of HLA-B57 micropolymorphism (MRM)
2018-10-24 | PXD009850 | Pride
Proteomics Influenza-derived peptide presentation by HLA-A*24:02
2021-04-08 | PXD020292 | Pride
Proteomics Identification of HLA-B*57:01-restricted endogenous and HIV epitopes
2018-02-19 | PXD004471 | Pride
Proteomics DIA acquisition of the immunopeptidomes of C1R-B*57:01 and C1R-A*02:01 cell lines
2023-02-13 | PXD034539 | Pride
Proteomics Influenza-derived peptide presentation by HLA-A*11:01
2022-02-15 | PXD028985 | Pride